Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions...
Pharmaceutical
Healthcare BPO Market to Grow by USD 17.30 Billion (2024-2028), Driven by Focus on Reducing Operational Costs, AI-Powered Report Highlights Market Transformation – Technavio
NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global healthcare business...
WakeMed Selects MedSpeed to Build Integrated Logistics Network
New network connects WakeMed points of care, reduces waste, and improves efficiency and care delivery RALEIGH, N.C., Nov. 12, 2024...
Cosmos Health Issues Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029 with 29.9% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 12, 2024 /PRNewswire/ -- The global artificial intelligence (AI) in drug discovery market is projected to...
Eric Giesing Joins Savillex as Chief Executive Officer
EDEN PRAIRIE, Minn., Nov. 12, 2024 /PRNewswire/ -- Savillex is pleased to announce the appointment of Eric Giesing as Chief...
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and...
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced...
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services...
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
NDA for CARDAMYST™ in PSVT under review by FDA; PDUFA March 27, 2025MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE...
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based...
Vincerx Pharma Reports Third Quarter 2024 Financial Results
Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data...
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq
November 12, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq Biodexa Pharmaceuticals PLC,...
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
Commenced enrollment and dosing in Phase 1 clinical study of PALI-2108 for the treatment of moderate-to-severe Ulcerative Colitis (UC) Carlsbad, CA,...
Mustang Bio Receives Positive Listing Determination from Nasdaq
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort...
Vitalchat Strengthens Leadership Team
Jerry Carter and Mackenzie Laughridge Join to Drive Growth and Expand Virtual Nursing SolutionsASHBURN, VA / ACCESSWIRE / November 12,...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,...
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression
Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective TreatmentMINNEAPOLIS and CARMARTHENSHIRE, United Kingdom,...